O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma

[1]  Jörg-Christian Tonn,et al.  Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Raphael Pfeffer,et al.  Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. , 2004, Journal of neurosurgery.

[3]  Paul Ashton,et al.  A Phase I Trial of Continuously Infused Intratumoral Bleomycin for the Treatment of Recurrent Glioblastoma Multiforme , 2002, Journal of Neuro-Oncology.

[4]  V. Sturm,et al.  Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy , 1996, European Journal of Nuclear Medicine.

[5]  K. Walter,et al.  Cytotoxicity of taxol in vitro against human and rat malignant brain tumors , 2004, Cancer Chemotherapy and Pharmacology.

[6]  Volker Sturm,et al.  Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma , 2003, Annals of neurology.

[7]  K. Herholz,et al.  Monitoring the Effect of Chemotherapy in a Mixed Glioma by C‐11‐Methionine PET , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[8]  K. Ohata,et al.  Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? , 2003, Journal of neurosurgery.

[9]  M. Westphal,et al.  Intracavitary chemotherapy for glioblastoma: present status and future directions. , 2003, Acta neurochirurgica. Supplement.

[10]  M. Pelizzo,et al.  Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  R. Bjerkvig,et al.  Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. , 2002, Current pharmaceutical biotechnology.

[12]  S E Maier,et al.  Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. , 2001, Cancer research.

[13]  R L Fine,et al.  Tissue Distribution and Antitumor Activity of Topotecan Delivered by Intracerebral Clysis in a Rat Glioma Model , 2000, Neurosurgery.

[14]  P Van Tassel,et al.  Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. , 2000, Radiology.

[15]  Wolfgang A. Weber,et al.  O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study , 2000, European Journal of Nuclear Medicine.

[16]  J P Johnson,et al.  Intracerebral clysis in a rat glioma model. , 2000, Neurosurgery.

[17]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[18]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  P. Black,et al.  Strategies in the surgical management of malignant gliomas. , 1998, Seminars in surgical oncology.

[20]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  R. Bjerkvig,et al.  Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. , 1997, British Journal of Cancer.

[22]  V. Sturm,et al.  11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. , 1997, Stereotactic and functional neurosurgery.

[23]  I. Kanno,et al.  Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. , 1996, AJNR. American journal of neuroradiology.

[24]  A. Brandes,et al.  The role of chemotherapy in recurrent malignant gliomas: an overview. , 1996, Cancer investigation.

[25]  P F Morrison,et al.  Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. , 1995, Journal of neurosurgery.

[26]  P. Burger,et al.  Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. , 1994, Cancer research.

[27]  P F Morrison,et al.  Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P J Kelly,et al.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. , 1993, Journal of neurosurgery.

[29]  F Shishido,et al.  Cerebral glioma: evaluation with methionine PET. , 1993, Radiology.

[30]  P. Black,et al.  MEDICAL PROGRESS : BRAIN TUMORS (SECOND OF TWO PARTS) , 1991 .

[31]  P M Black,et al.  Brain tumors. Part 1. , 1991, The New England journal of medicine.

[32]  P M Black,et al.  Brain tumors. Part 2. , 1991, The New England journal of medicine.

[33]  Y. Olsson,et al.  Positron Emission Tomography and Computed Tomography in Differential Diagnosis between Recurrent or Residual Glioma and Treatment-Induced Brain Lesions , 1989, Acta radiologica.

[34]  A. Syrota,et al.  [11C]L-methionine uptake in gliomas. , 1989, Neurosurgery.

[35]  R L Ehman,et al.  Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. , 1988, Radiology.